Transchromosomic Hens Producing Biotherapeutic Drugs
Basic science discoveries have led to the development of a series of human biotherapeutic drugs for the treatment of cancer and HIV as well as many other diseases. Currently there are over 400 drugs in clinical trials just for the first two diseases. The current biotherapeutics' manufacturing platforms have not kept pace resulting in a dramatic rise in treatment cost and more importantly unmet therapeutic needs. Avian transgenesis is an emerging technology that has the potential to radically increase the US manufacturing capacity of biotherapeuticals. AviGenics, Inc proposes a novel recombinant protein manufacturing platform that will allow us to express human therapeutic molecules in the egg white of hens.
Small Business Information at Submission:
111 Riverbend Rd. Athens, GA 30605
Number of Employees: